Chinese Medical Device Provider Blue Sail Picks Up 10.16% Stake In Artificial Heart Developer

Login to View

Blue Sail announced on Wednesday that the company and some of its executives have paid RMB101.60 million (US$14.71 million) for a 10.16% stake in Tongxin Medical, marking the latest effort made by Blue Sail to further raise the stakes in the artificial heart field.

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access Over 11,000 stories and data posts over the past 8 years!

Register Now

Already have an account or paid subscription? Log in

China Money Network Subscription